Cardiovascular Risk Factors in Acromegaly before and after Normalization of Serum IGF-I Levels with the GH Antagonist Pegvisomant-Reference-Cited by-同舟云学术

Cardiovascular Risk Factors in Acromegaly before and after Normalization of Serum IGF-I Levels with the GH Antagonist Pegvisomant

Published:2002-04-01 Issue:4 Volume:87 Page:1692-1699
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Sesmilo Gemma¹,Fairfield Wesley P.²,Katznelson Laurence²,Pulaski Karen²,Freda Pamela U.³,Bonert Vivien⁴,Dimaraki Eleni⁵,Stavrou Stavros⁶,Vance Mary Lee⁷,Hayden Douglas²,Klibanski Anne²

Affiliation:

1. Servicio de Endocrinologia (G.S.), Hospital Clínic de Barcelona, Barcelona, Spain

2. Neuroendocrine Clinical Center (W.F., L.K., K.P., D.H., A.K.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114

3. Columbia College of Physicians and Surgeons (P.F.), New York, New York

4. Pituitary Center (V.B.), Cedars Sinai Hospital, Los Angeles, California

5. Division of Endocrinology and Metabolism (E.D.), University of Michigan, Ann Arbor, Michigan 48109

6. Division of Endocrinology (S.S.), New York University Medical Center, New York, New York 10016

7. Department of Internal Medicine (Endocrinology and Metabolism) (M.L.V.), University of Virginia Health System, Charlottesville, Virginia 22908

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/87/4/1692/10405414/jcem1692.pdf

Reference52 articles.

1. Mortality in acromegaly;Wright;Q J Med,1970

2. Epidemiology of acromegaly in the Newcastle region;Alexander;Clin Endocrinol (Oxf),1980

3. Acromegaly and cardiovascular disorders. A prospective study;McGuffin Jr;Ann Intern Med,1974

4. Acromegaly;Nabarro;Clin Endocrinol (Oxf),1987

5. Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients;Lie;Am Heart J,1980

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surgical and non-surgical interventions for primary and salvage treatment of growth hormone-secreting pituitary adenomas in adults;Cochrane Database of Systematic Reviews;2024-02-06

2. Efficacy and Safety of Pegvisomant in the Treatment of Acromegaly;Archives of Medical Research;2023-12

3. Effects of endocrine disorders on lipids and lipoproteins;Best Practice & Research Clinical Endocrinology & Metabolism;2023-05

4. Control of acromegaly in more than 90% of patients after 10 years of pegvisomant therapy: an European referral centre real-life experience;Journal of Endocrinological Investigation;2023-03-09

5. Pegvisomant in the treatment of acromegaly;Vnitřní lékařství;2022-10-31